Neoadjuvant versus adjuvant chemoradiotherapy for esophageal carcinoma: a systematic review and meta-analysis
Li Zhang(Fourth Hospital of Changsha), Liming Wu(Chongqing Technology and Business University), Li Niu(Anhui Medical University), Yu Gao(Anhui Medical University), Yichun Wang(Anhui Medical University), Wanli Xia(Anhui Medical University), Ningning Kang(Anhui Medical University), Liyang Zhu(Huazhong Agricultural University), Dongbo Chen(Diponegoro University), Mei Kang, Mingwei Yang(Sun Yat-sen University)
Cited by 0
Related Papers
A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs
|Cell stem cell|2008|4k
Platelet Glycoprotein Ibα Is a Counterreceptor for the Leukocyte Integrin Mac-1 (Cd11b/Cd18)
|The Journal of Experimental Medicine|2000|582
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study
|Journal of Clinical Oncology|2022|334
Large-Scale Gene-Centric Meta-analysis across 32 Studies Identifies Multiple Lipid Loci
|The American Journal of Human Genetics|2012|269